{
    "2020-12-07": [
        [
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：政策压制效应渐弱 重点把握核心资产价值",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "政策压制",
                        "核心资产"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业12月月报：静待医药政策落地期 关注重磅品种研发进展和优质细分赛道",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "政策落地",
                        "重磅品种",
                        "研发进展",
                        "优质细分赛道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医药反弹OR反抽？",
                "features": {
                    "keywords": [
                        "医药",
                        "反弹",
                        "反抽"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "ambiguous"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业研究周报：从批签发变化来看血制品行业有望迎来高景气度",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "批签发",
                        "血制品",
                        "高景气度"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物",
                        "血制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}